Pulmonary Drug Delivery Devices Market Is Likely to Attain a Value of US $43.05 Bn by the End of 2024
According to the research report, the worldwide market for pulmonary drug delivery devices, which stood at US$32.2 bn in 2015, is expected to progress at a CAGR of 3.30% between 2016 and 2024 and reach US$43.05 bn by the end of the forecast period. The application of these devices is higher in the asthma segment and is expected to remain so over the next few years, thanks to the robust pipeline of drugs for the treatment of asthma.
View full press release